abagovomab 10
abciximab 20
abituzumab 6
abrilumab 0
actoxumab 4
adalimumab 7
aducanumab 3
afasevikumab 0
alacizumab_pegol 0
alemtuzumab 9
alirocumab 6
amatuximab 8
andecaliximab 9
anifrolumab 11
anrukinzumab 10
aprutumab 6
aprutumab_ixadotin 6
arcitumomab 4
ascrinvacumab 0
atezolizumab 4
atinumab 10
avelumab 3
basiliximab 3
bavituximab 6
begelomab 3
benralizumab 13
bevacizumab_beta 7
bezlotoxumab 4
bimagrumab 3
bleselumab 0
blinatumomab 10
blosozumab 10
bococizumab 12
brazikumab 8
brentuximab_vedotin 8
briakinumab 8
brodalumab 4
brolucizumab 11
brontictuzumab 8
burosumab 7
cabiralizumab 11
camrelizumab 3
canakinumab 3
cantuzumab_ravtansin 17
carlumab 8
carotuximab 3
cergutuzumab_amunaleukin2 16
cergutuzumab_amunaleukin 16
certolizumab_pegol 13
cetiximab 18
citatuzumab_bogatox 18
cixutumumab 12
clivatuzumab_tetraxetan 7
codrituzumab 15
conatumumab 9
concizumab 11
crenezumab 10
crizanlizumab 10
crotedumab 9
dacetuzumab 11
daclizumab 6
dalotuzumab 10
dapirolizumab_pegol 11
daratumumab 7
dectrekumab 4
demcizumab 10
denosumab 3
depatuxizumab 8
depatuxizumab_mafodotin 8
dezamizumab 6
dinutuximab 10
diridavumab 0
domagrozumab 0
drozitumab 6
duligotuzumab 10
durvalumab 5
dusigitumab 6
efalizumab 17
efungumab 3
eldelumab 5
elezanumab 3
elgemtumab 4
elotuzumab 8
emactuzumab 4
emapalumab 11
emibetuzumab 6
enavatuzumab 7
enfortumab_vedotin 3
enoblituzumab 7
enokizumab 10
enoticumab 7
ensituximab 7
eptinezumab 0
erenumab 4
etaracizumab 10
etrolizumab 18
evinacumab 7
evolocumab 3
farletuzumab 0
fasinumab 9
fezakinumab 10
fibatuzumab 3
ficlatuzumab 19
firivumab 14
flanvotumab 7
fletikumab 7
foralumab 3
foravirumab 9
fremanezumab 17
fresolimumab 9
fulranumab 11
futuximab 3
galcanezumab 6
ganitumab 11
gantenerumab 6
gemetuzumab 12
gemtuzumab2 8
gemtuzumab 8
gevokizumab 14
girentuximab 8
glembatumumab 12
glembatumumab_vedotin 12
guselkumab 12
ibalizumab 16
ibritumomab 0
icrucumab 3
idarucizumab 17
ifabotuzumab 3
imalumab 8
imgatuzumab 13
inclacumab 7
indatuximab_ravtansin 13
indusatumab 9
inebilizumab 8
intetumumab 3
iodine_girentuximab 9
ipilimumab 0
iratumumab 0
isatuximab 10
itolizumab 0
ixekizumab 14
labetuzumab_govitecan 15
lambrolizumab 9
lampalizumab 15
lanadelumab 13
landogrozumab 0
laprituximab 6
lebrikizumab 15
lendalizumab 15
lenzilumab 10
lifastuzumab_vedotin 4
ligelizumab 9
lilotomab 14
lirilumab 10
lodelcizumab 13
lokivetmab 6
lorvotuzumab_mertansin 0
lucatumumab 3
lumretuzumab 8
lupartumab 3
lutikizumab 9
margetuximab 9
milatuzumab 9
mirvetuximab 13
mirvetuximab_soravtansin 13
modotuximab 13
mogamulizumab 12
monalizumab 13
motavizumab 17
moxetumomab_pasudotox 11
namilumab 13
naratuximab 4
naratuximab_emtansin 4
narnatumab 7
navicixizumab2 16
navicixizumab 10
navivumab 6
necitumumab 3
nemolizumab 19
nesvacumab 0
nivolumab 7
obiltoxaximab 4
obinutuzumab 18
ocaratuzumab 9
ofatumumab 9
olaratumab 4
olokizumab 13
omalizumab 13
onartuzumab 8
ontuxizumab 11
opicinumab 9
orticumab 0
otelixizumab 6
oxelumab 3
ozanezumab 12
pamrevlumab 3
panobacumab 17
parsatuzumab 9
pasotuxizumab 7
pateclizumab 8
patritumab 4
pembrolizumab 9
perakizumab 6
pidilizumab 5
pinatuzumab_vedotin 6
plozalizumab 11
pogalizumab 12
polatuzumab_vedotin 14
ponezumab 13
prezalumab 13
pritoxaximab 10
quilizumab 4
racotumomab 12
radretumab 0
ralpancizumab 16
ramucirumab 3
ranevetmab 12
ranibizumab 9
refanezumab 9
remtolumab 5
rilotumumab 10
rinucumab 3
risankizumab 6
rituximab 4
rivabazumab 8
robatumumab 10
roledumab 5
romosozumab 8
rontalizumab 10
rosmantuzumab 3
rozanolixizumab 10
sacituzumab 18
sacituzumab_govitecan 18
samalizumab 15
sapelizumab 8
sarilumab 0
secukinumab 3
seribantumab 4
setoxaximab 17
sifalimumab 6
siltuximab 7
simtuzumab 11
sirukumab 6
solanezumab 14
solitomab 13
stamulumab 0
suptavumab 8
suvizumab 11
tabalumab 3
tadocizumab 3
tamtuvetmab 5
tanezumab 17
tarextumab 3
tavolixizumab 0
telisotuzumab 13
teplizumab 6
tesidolumab 3
tezepelumab 11
tigatuzumab 9
tildrakizumab 14
timolumab 3
tisotumab 3
tosatoxumab 16
tositumomab 0
tralokinumab 15
trastuzumab 13
tregalizumab 8
trevogrumab 5
ublituximab 6
urelumab 6
ustekinumab 15
utomilumab 3
vadastuximab 4
vadastuximab_talirin 4
vandortuzumab_vedotin 3
vantictumab 9
vanucizumab2 7
vanucizumab 12
varlilumab 3
vatelizumab 7
vedolizumab 6
veltuzumab 3
vesencumab 3
vorsetuzumab 14
vorsetuzumab_mafodotin 14
vunakizumab 11
xentuzumab 7
zatuximab 13
